U.S. MARKETS FOR PERCUTANEOUS VERTEBROPLASTY AND VERTEBRAL AUGMENTATION PRODUCTS AND THERMAL INTRADISCAL DEVICES

139 Pages | 40 Exhibits | 2012 Analysis | Forecasts Through 2016

OVERVIEW:
Back pain is one of the most common medical problems in the United States (U.S.), affecting 8 out of 10 people at some point during their lives. Degeneration of an intervertebral disc that results in functionally limiting low back pain is a common condition that prompts patients to seek treatment. For the appropriate patient subset, a percutaneous thermal intradiscal procedure may be employed to treat chronic low back pain. In addition, vertebral compression fractures are a leading cause of disability and morbidity in the elderly population; elderly patients with collapsed vertebrae due to osteoporosis have an impaired ability to heal and may suffer severe spinal deformity. Vertebroplasty and vertebral augmentation or kyphoplasty are minimally invasive techniques used to treat symptomatic vertebral compression fractures resulting from osteoporosis and certain metastatic tumors.

The combined U.S. market for percutaneous vertebroplasty and vertebral augmentation products and thermal intradiscal devices is projected to increase at a compound annual rate of 2.5% during the forecast period covered by this report (from 2011 to 2016).

This dynamic new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of percutaneous vertebroplasty and vertebral augmentation products and thermal intradiscal devices. The market segments that are covered by this report include percutaneous vertebroplasty and kyphoplasty systems and thermal intradiscal devices (including nucleoplasty and intradiscal biacuplasty and electrothermal therapy products).

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Selected Spinal Disorders 
	a. Degenerative Disc Disease 
	b. Disc Herniation 
	c. Spinal Tumors 
	d. Traumatic Spinal Injuries 
	e. Vertebral Fractures 
ii. Percutaneous Vertebroplasty and Vertebral Augmentation Products Market 
	a. Market Analysis 
iii. Percutaneous Thermal Intradiscal Products Market 
	a. Intradiscal Biacuplasty 
	b. Intradiscal Electrothermal Therapy 
	c. Plasma Disc Decompression 
	d. Market Analysis 
iv. Combined Market Forecast 
v. Methodology 

Exhibit ES-1: Prevalence of Selected Spinal Disorders, 2011-2016 
Exhibit ES-2: Incidence of Selected Spinal Disorders, 2011-2016 
Exhibit ES-3: Vertebroplasty and Vertebral Augmentation Products, Market Forecast, 2011-2016 
Exhibit ES-4: Percutaneous Thermal Intradiscal Products, Market Forecast, 2011-2016 
Exhibit ES-5: Percutaneous Vertebroplasty/Vertebral Augmentation and Thermal Intradiscal Products, Combined Market Forecast, 2011-2016 

1. CLINICAL OVERVIEW

1.1 The Human Spine 
1.2 Bone Structure and Function 
	1.2.1 Bone Formation 
	1.2.2 Cellular Framework 
		1.2.2.1 Osteoblasts 
		1.2.2.2 Osteocytes 
		1.2.2.3 Osteoclasts 
	1.2.3 The Fracture Healing Process 
	1.2.4 Factors Affecting Bone Physiology 
		1.2.4.1 The Effect of Physical Stress on Bone Remodeling 
		1.2.4.2 Age and Gender 
		1.2.4.3 Physical Activity 
		1.2.4.4 Obesity 
		1.2.4.5 Cigarette Smoking, Alcohol, and Caffeine 
		1.2.4.6 Nutritional Deficiencies 
1.3 Selected Spinal Disorders 
	1.3.1 Disc Herniation 
	1.3.2 Degenerative Disc Disease 
		1.3.2.1 Arthritis 
			1.3.2.1.1 Osteoarthritis 
			1.3.2.1.2 Rheumatoid Arthritis 
			1.3.2.1.3 Ankylosing Spondylitis 
		1.3.2.2 Osteoporosis 
		1.3.2.3 Spondylosis 
	1.3.3 Abnormal Curvature of the Spine 
		1.3.3.1 Scoliosis 
		1.3.3.2 Kyphosis and Lordosis 
	1.3.4 Spondylolisthesis 
	1.3.5 Stenosis 
	1.3.6 Spinal Tumors 
	1.3.7 Traumatic Spinal Injuries 
	1.3.8 Vertebral Fractures 
1.4 Spine Treatment Options 
	1.4.1 Spinal Decompression 
		1.4.1.1 Corpectomy 
		1.4.1.2 Discectomy 
		1.4.1.3 Facetectomy 
		1.4.1.4 Foraminotomy/Foraminectomy 
		1.4.1.5 Laminotomy/Laminectomy 
	1.4.2 Spinal Fusion 
		1.4.2.1 Instrumented versus Noninstrumented Spinal Fusion 
			1.4.2.1.1 Instrumented Spinal Fusion 
			1.4.2.1.2 Noninstrumented Spinal Fusion 
		1.4.2.2 Types of Fusion 
			1.4.2.2.1 Cervical Fusion 
			1.4.2.2.2 Anterior Cervical Fusion 
			1.4.2.2.3 Posterior Cervical Fusion 
			1.4.2.2.4 Interbody Fusion 
			1.4.2.2.5 Lumbar Fusion 
				1.4.2.2.5.1 Anterior Lumbar Interbody Fusion 
				1.4.2.2.5.2 Posterior Lumbar Interbody Fusion 
				1.4.2.2.5.3 Transforaminal Lumbar Interbody Fusion 
			1.4.2.2.6 Posterolateral Fusion 
			1.4.2.2.7 360-Degree Fusion 
			1.4.2.2.8 Thoracic and Thoracolumbar Fusion 
			1.4.2.2.9 Percutaneous or Minimally Invasive Fusion 
	1.4.3 Posterior Dynamic Stabilization 
1.5 Market Dynamics 
	1.5.1 Demographics 
	1.5.2 Reimbursement 
	1.5.3 Patient Protection and Affordable Care Act 
	1.5.4 Federal Oversight of Physician/Corporate Relationships 
	1.5.5 Procedure Volumes Forecast 

Exhibit 1-1: The Human Spine 
Exhibit 1-2: The Structure of Collagen 
Exhibit 1-3: The Structure of Hydroxyapatite 
Exhibit 1-4: The Structure of Bone 
Exhibit 1-5: Bone Density Averages in the General Population 
Exhibit 1-6: Bone Density Averages in Olympic Athletes in Comparison  with the General Population 
Exhibit 1-7: Number of Overweight and Obese People, 2011 and 2016 
Exhibit 1-8: A Herniated Disc 
Exhibit 1-9: Bone Density in Normal and Osteoporotic Bone Tissue 
Exhibit 1-10: Prevalence of Selected Spinal Disorders, 2011-2016 
Exhibit 1-11: Incidence of Selected Spinal Disorders, 2011-2016 
Exhibit 1-12: The Anatomy of a Spinal Segment 
Exhibit 1-13: Noninstrumented Spinal Fusion 
Exhibit 1-14: United States Population Growth Trends 
Exhibit 1-15: Spinal Fusion Diagnosis-Related Groups and Associated Medicare Reimbursement 
Exhibit 1-16: Spinal Fusion, Procedure Volumes Forecast, 2010-2016 

2. PERCUTANEOUS VERTEBROPLASTY AND VERTEBRAL AUGMENTATION PRODUCTS MARKET

2.1 Vertebroplasty 
	2.1.1 Polymethylmethacrylate Alternatives 
2.2 Kyphoplasty 
2.3 Technology Assessments 
2.4 Reimbursement 
2.5 Vertebroplasty Products 
2.6 Percutaneous Vertebral Augmentation Products 
	2.6.1 Emerging Vertebral Augmentation Products 
2.7 Market Analysis 
2.8 Competitive Analysis 

Exhibit 2-1: The Vertebroplasty Procedure 
Exhibit 2-2: Vertebroplasty Indications and Contraindications 
Exhibit 2-3: The Balloon Kyphoplasty Procedure 
Exhibit 2-4: 2012, Percutaneous Vertebroplasty, Medicare Physician Reimbursement 
Exhibit 2-5: 2012, Percutaneous Vertebral Augmentation, Medicare Physician Reimbursement 
Exhibit 2-6: 2012, Percutaneous Vertebral Augmentation and Percutaneous Vertebroplasty, Medicare Hospital Inpatient, Possible MS-DRG Groups 
Exhibit 2-7: 2012, Percutaneous Vertebroplasty, Medicare Hospital Outpatient and Ambulatory Surgery Center Reimbursement 
Exhibit 2-8: 2012, Percutaneous Vertebral Augmentation, Medicare Hospital Outpatient and Ambulatory Surgery Center Reimbursement 
Exhibit 2-9: 2012, Selected Vertebroplasty Products 
Exhibit 2-10: 2012, Selected Percutaneous Vertebral Augmentation Products 
Exhibit 2-11: 2012, Selected Emerging Vertebroplasty and Vertebral Augmentation Products 
Exhibit 2-12: Vertebroplasty and Vertebral Augmentation Products, Market Forecast, 2011-2016 
Exhibit 2-13: 2011, Vertebroplasty and Vertebral Augmentation Products Market, Share by Supplier 

3. PERCUTANEOUS THERMAL INTRADISCAL PRODUCTS MARKET

3.1 Intradiscal Annuloplasty 
	3.1.1 Intradiscal Biacuplasty 
	3.1.2 Intradiscal Electrothermal Therapy 
3.2 Plasma Disc Decompression 
3.3 Clinical Trials 
	3.3.1 Intradiscal Biacuplasty 
	3.3.2 Intradiscal Electrothermal Therapy 
	3.3.3 Nucleoplasty 
3.4 Reimbursement 
3.5 Emerging Technology 
3.6 Market Analysis 
3.7 Competitive Analysis 

Exhibit 3-1: Intradiscal Biacuplasty Using the TransDiscal System 
Exhibit 3-2: The SpineCath Intradiscal Catheter 
Exhibit 3-3: The Plasma Disc Decompression Procedure 
Exhibit 3-4: 2012, Selected Percutaneous Thermal Intradiscal Products 
Exhibit 3-5: Percutaneous Thermal Intradiscal Products,  Market Forecast, 2011-2016 
Exhibit 3-6: 2011, Percutaneous Thermal Intradiscal Products Market, Share by Supplier 

4. COMPANY PROFILES

4.1 ArthroCare Corporation 
4.2 CareFusion Corporation 
4.3 Medtronic, Inc. 
4.4 NeuroTherm, Inc. 
4.5 Stryker Corporation 

APPENDIX:  COMPANY LISTING 



COMPANIES COVERED:

  1. Alphatec Spine, Inc.
  2. ArthroCare Corporation
  3. Ascendx Spine
  4. A-Spine Holding Group Corporation
  5. Baylis Medical Company
  6. Benvenue Medical, Inc.
  7. Biomet, Inc.
  8. BoneSupport AB
  9. Cardinal Health, Inc.
  10. CareFusion Corporation
  11. Cook Group, Inc.
  12. Crosstrees Medical, Inc.
  13. DePuy Synthes/ Johnson & Johnson
  14. DFINE, Inc.
  15. Heraeus Medical GmbH
  16. Integra LifeSciences Corporation
  17. Kimberly-Clark Worldwide, Inc.
  18. Medtronic, Inc.
  19. NeuroTherm, Inc.
  20. Osseon Therapeutics, Inc.
  21. Relievant Medsystems, Inc.
  22. Sintea Plustek Srl
  23. Skeltex Technologies, Inc.
  24. Smith & Nephew, Inc.
  25. Soteira, Inc.
  26. Spine Wave, Inc.
  27. Stryker Corporation
  28. Tecres S.p.A.
  29. Teknimed SA
Contact Us

Need help finding medtech research? Let us help you!